000 02062 a2200553 4500
005 20250515174111.0
264 0 _c20091109
008 200911s 0 0 eng d
022 _a1873-2402
024 7 _a10.1016/j.biopsych.2009.04.025
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDarmopil, Sanja
245 0 0 _aGenetic inactivation of dopamine D1 but not D2 receptors inhibits L-DOPA-induced dyskinesia and histone activation.
_h[electronic resource]
260 _bBiological psychiatry
_cSep 2009
300 _a603-13 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAcetylation
_xdrug effects
650 0 4 _aAnalysis of Variance
650 0 4 _aAnimals
650 0 4 _aAntiparkinson Agents
_xadverse effects
650 0 4 _aBehavior, Animal
_xdrug effects
650 0 4 _aCorpus Striatum
_xpathology
650 0 4 _aDisease Models, Animal
650 0 4 _aDynorphins
_xmetabolism
650 0 4 _aDyskinesia, Drug-Induced
_xetiology
650 0 4 _aExtracellular Signal-Regulated MAP Kinases
_xmetabolism
650 0 4 _aFunctional Laterality
650 0 4 _aGene Expression Regulation
_xdrug effects
650 0 4 _aHistones
_xmetabolism
650 0 4 _aLevodopa
_xadverse effects
650 0 4 _aMice
650 0 4 _aMice, Knockout
650 0 4 _aMotor Activity
_xdrug effects
650 0 4 _aNeurons
_xdrug effects
650 0 4 _aOxidopamine
650 0 4 _aParkinsonian Disorders
_xchemically induced
650 0 4 _aPhosphorylation
_xdrug effects
650 0 4 _aProto-Oncogene Proteins c-fos
_xmetabolism
650 0 4 _aReceptors, Dopamine D1
_xdeficiency
650 0 4 _aReceptors, Dopamine D2
_xdeficiency
650 0 4 _aStatistics as Topic
650 0 4 _aTyrosine 3-Monooxygenase
_xmetabolism
700 1 _aMartín, Ana B
700 1 _aDe Diego, Irene Ruiz
700 1 _aAres, Sara
700 1 _aMoratalla, Rosario
773 0 _tBiological psychiatry
_gvol. 66
_gno. 6
_gp. 603-13
856 4 0 _uhttps://doi.org/10.1016/j.biopsych.2009.04.025
_zAvailable from publisher's website
999 _c18940047
_d18940047